Home
Markets
Charts & Ideas
Algo
News
Store
Brokers
Download
Economic Calendar
Trading Signals
WebTerminal
Heatmap
Type
/
to search: @user, $symbol
Search
Log in
Create an account
English
Русский
中文
Español
Português
日本語
Deutsch
한국어
Français
Italiano
Türkçe
MLTX
#2255
MoonLake Immunotherapeutics Class A Ordinary Shares
18.780
0
USD
+1.90%
Sector:
Healthcare
Base:
USD
Profit Currency:
USD
Daily Range
Year Range
Daily Change
+1.90%
Monthly Change
+9.00%
6 month change
+96.44%
Year Change
+96.44%
Previous Close
18.430
0
Open
18.780
0
Bid
Ask
Low
18.780
0
High
18.780
0
Volume
87
Markets
US Stock Market
Healthcare
MLTX
Open full chart
Financials
Overview
Statement
Statistics
Quarterly
Annual
Value
2020
2021
2022
2023
2024
2025
TTM
Key stats
Total common shares outstanding
11.93 M
11.93 M
39.15 M
62.87 M
63.28 M
71.73 M
—
Valuation ratios
Enterprise value
—
—
561.39 M
3.37 B
3.29 B
686.56 M
6 B
Price to earnings ratio
—
—
-6.49
-81.58
-28.65
-3.73
-39.79
Price to sales ratio
—
—
995.06
19.31 K
-80.7 K
1 418.42
-132.71 K
Price to cash flow ratio
—
—
-5.79
-68.38
-29.2
-4.33
-42.25
Price to book ratio
—
—
6.62
5.9
7.62
2.79
6.17
Enterprise value to EBITDA ratio
—
—
-26.63
-203.49
-72.13
-10.35
-101.81
Profitability ratios
Return on assets %
—
-0.04
-0.65
-0.07
-0.25
-0.54
-0.51
Return on equity %
—
0.64
-0.73
-0.07
-0.26
-0.75
-0.7
Return on invested capital %
—
—
-427.73
-1 699.61
-2 635.87
-2 843.87
-2 987.24
Gross margin %
—
—
100
100
100
100
400
Operating margin %
—
—
-20 K
-35.73 K
339.19 K
-40.87 K
133.9 K
EBITDA margin %
—
—
-19.9 K
-35.62 K
336.01 K
-40.34 K
133.28 K
Net margin %
—
—
-15.36 K
-23.77 K
281.93 K
-37.95 K
113.7 K
Liquidity ratios
Quick ratio
—
—
—
—
—
—
—
Current ratio
12.93
0.21
9.98
51.59
21.11
9.27
55.53
Inventory turnover
—
—
—
—
—
—
—
Asset turnover
—
—
0
0
-0
0
0
Solvency ratios
Debt to assets ratio
0
0
—
—
—
0.18
0.67
Debt to equity ratio
0.01
0
—
—
—
0.25
0.91
Long term debt to total assets ratio
0
0
—
—
—
0.17
0.65
Long term debt to total equity ratio
0.01
0
—
—
—
0.24
0.89
Per share metrics
Operating cash flow per share
—
-0
-1.9
-0.87
-1.85
-3.04
-3.08
EBIT per share
—
—
-2.2
-1.1
-2.28
-3.79
-3.84
EBITDA per share
—
—
-2.2
-1.1
-2.25
-3.75
-3.8
Total debt per share
—
0
—
—
—
1.17
4.76
Cash per share
—
0
2.46
10.4
7.13
6.11
26.44
Net current asset value per share
—
0
2.61
10.47
7.54
6.54
28.24
Tangible book value per share
—
-0.02
1.67
10.09
7.11
4.72
21.32
Working capital per share
—
-0.01
2.34
10.26
7.19
5.84
25.96
Book value per share
—
-0.02
1.67
10.09
7.11
4.72
21.32
News
Clear Street raises Moonlake stock price target on IL-17 data
Cantor Fitzgerald reiterates Moonlake stock rating on axSpA potential
Moonlake Immunotherapeutics stock price target raised to $40 by H.C. Wainwright on trial results
MoonLake: Downgrade To Buy As Sonelokimab Still Has A BLA Shot On Goal (NASDAQ:MLTX)
MoonLake Immunotherapeutics (MLTX) Analyst/Investor Day - Slideshow (NASDAQ:MLTX) 2026-02-23
MoonLake Immunotherapeutics (MLTX) Analyst/Investor Day Transcript
MoonLake stock surges on positive axSpA trial data
MoonLake stock surges 63% after InvestingPro Fair Value call
MoonLake reports positive phase 2 axial spondyloarthritis data
ImageneBio appoints Dr. Porter-Brown as Chief Medical Officer
BTIG reiterates Buy rating on Moonlake Immunotherapeutics stock ahead of data
H.C. Wainwright reiterates Buy rating on Moonlake stock with $32 target